Confronting the epidemic of hepatitis B and C

Mark A. Feitelson, Mark A Zern

Research output: Contribution to journalArticlepeer-review


With 350 million people designated as carriers of hepatitis B, and 170 million chronically infected with hepatitis C, new treatments are urgently needed.

Original languageEnglish (US)
Pages (from-to)140-144
Number of pages5
JournalChemistry and Industry (London)
Issue number4
StatePublished - 1999
Externally publishedYes

ASJC Scopus subject areas

  • Chemistry (miscellaneous)


Dive into the research topics of 'Confronting the epidemic of hepatitis B and C'. Together they form a unique fingerprint.

Cite this